Submitted by Anonymous (not verified) on 29 October 2025 - 15:25
Human medicines European public assessment report (EPAR): Lytgobi, futibatinib, Date of authorisation: 04/07/2023, Revision: 3, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Lytgobi, futibatinib, Date of authorisation: 04/07/2023, Revision: 3, Status: Authorised